Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kevin Dinnell is active.

Publication


Featured researches published by Kevin Dinnell.


Bioorganic & Medicinal Chemistry Letters | 2001

2-Aryl Indole NK1 receptor antagonists: optimisation of indole substitution

Laura Catherine Cooper; Gary G. Chicchi; Kevin Dinnell; Jason Matthew Elliott; Gregory John Hollingworth; Marc M. Kurtz; Karen L Locker; Denise Morrison; Duncan E. Shaw; Kwei-Lan Tsao; Alan P. Watt; Angela R. Williams; Christopher John Swain

The synthesis and biological evaluation of a series of 2-aryl indoles with high affinity for the human neurokinin-1 (hNK1) receptor are reported, concentrating on optimisation of the indole substitution.


Bioorganic & Medicinal Chemistry Letters | 2001

2-Aryl indole NK1 receptor antagonists: optimisation of the 2-Aryl ring and the indole nitrogen substituent

Kevin Dinnell; Gary G. Chicchi; Madhumeeta J Dhar; Jason Matthew Elliott; Gregory John Hollingworth; Marc M. Kurtz; Mark Peter Ridgill; Wayne Rycroft; Kwei-Lan Tsao; Angela R. Williams; Christopher John Swain

Novel 2-aryl indole hNK1 receptor ligands were prepared utilising palladium cross-coupling chemistry of a late intermediate as a key step. Compounds with high hNK1 receptor binding affinity and good brain penetration (e.g., 9d) were synthesised.


Tetrahedron Letters | 1999

A convenient method for the preparation of aryl cyclopropyl ethers from phenols

Gregory John Hollingworth; Kevin Dinnell; Laura C. Dickinson; Jason Matthew Elliott; Janusz Jozef Kulagowski; Christopher John Swain; Christopher G. Thomson

Abstract A general method for the synthesis of cyclopropyl ethers from phenols is described. Alkylation of a phenol using 1-iodo-1-(phenylthio)cyclopropane followed by removal of the phenylthio group furnishes the cyclopropyl ethers in modest to excellent yields. The procedure tolerates a wide range of functional groups.


Bioorganic & Medicinal Chemistry Letters | 2002

4,4-Disubstituted cyclohexylamine NK1 receptor antagonists II

Jason Matthew Elliott; José L. Castro; Gary G. Chicchi; Laura Catherine Cooper; Kevin Dinnell; Gregory John Hollingworth; Mark Peter Ridgill; Wayne Rycroft; Marc M. Kurtz; Duncan E. Shaw; Christopher John Swain; Kwei-Lan Tsao; Lihu Yang

Abstract A series of novel 4,4-disubstituted cyclohexylamine based NK 1 antagonists is described. The effect of changes to the C 1 –C 4 relative stereochemistry on the cyclohexane ring and replacements for the flexible linker are discussed, leading to the identification of compounds with high affinity and good in vivo duration of action.


Archive | 2001

Sulphones which modulate the action of gamma-secretase

Jose Luis Castro Pineiro; Ian Churcher; Kevin Dinnell; Timothy Harrison; Sonia Kerrad; Alan Nadin; Paul Joseph Oakley; Andrew Pate Owens; Duncan Edward Shaw; Martin Richard Teall; Susannah William; Brian John Williams


Archive | 2001

2-aryl indole derivatives and their use as therapeutic agents

Kevin Dinnell; Jason Matthew Elliott; Gregory John Hollingworth; Mark Peter Ridgill; Duncan Edward Shaw


Archive | 2002

Novel cyclohexyl sulphones

Ian Churcher; Kevin Dinnell; Timothy Harrison; Sonia Kerrad; Alan John Nadin; Paul Joseph Oakley; Duncan Edward Shaw; Martin Richard Teall; Susannah Williams; Brian John Williams


Archive | 2000

2-aryl indole derivatives as antagonists of tachykinins

Kevin T. Chapman; Kevin Dinnell; Jason Matthew Elliott; Gregory John Hollingworth; Steven M. Hutchins; Duncan Edward Shaw; Christopher A. Willoughby


Archive | 2001

Cyclohexane derivatives and their use as therapeutic agents

Pineiro Jose Luis Castro; Kevin Dinnell; Jason Matthew Elliott; Gregory John Hollingworth; Duncan Edward Shaw; Christopher John Swain


Archive | 2004

Cyclic sulfonamides for inhibition of gamma-secretase

Kevin Dinnell; Timothy Harrison; Alan John Nadin; Andrew Pate Owens; Duncan Edward Shaw; Brian John Williams

Researchain Logo
Decentralizing Knowledge